Brokerages believe select firms will continue to benefit but upside for others may reverse in Sept quarter
Shrikant Chouhan of Kotak Securities continues to like Deepak Nitrite from a near-term perspective, as elevated phenol spreads and a stronger Q1FY27 should support robust earnings
Nishchal Jain of Share.Market believes that the 'Golden Crossover' suggests the beginning of a multi-quarter recovery cycle for Fortis Healthcare, Deepak Fertilisers and Deepak Nitrite.